pipette
ENEnglish

Cell-free telomeric DNA and integrity indices in axial spondyloarthritis: associations with somatic and mental burden: a case-control study.

M. Husakova, B. Banerjee, P. Skubica, K. Pavelka, K. Kucharikova, J. Kotrs, L. Senolt, M. Olejarova, P. Mohr, P. Dankova

Preprint

En palabras de los autores

Objectives: Depression and anxiety in axial spondyloarthritis (axSpA) are associated with higher disease activity. This study examined whether circulating cell-free nuclear DNA (cf-nDNA), mitochondrial DNA (cf-mtDNA), relative telomere length (T/S ratio), and DNA integrity index (DII) are associated with mental burden and disease characteristics in axSpA. Methods: Plasma cf-nDNA, cf-mtDNA, T/S ratio, and ALU-247/ALU-115 ratio (DII) were analysed in 79 patients with axSpA and 88 age- and sex-matched healthy controls (HCs). Mental burden was assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.), Beck Depression Inventory-II, and Beck Anxiety Inventory. Clinical measures included the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP), and radiographic disease pattern. Results: Sex differences were observed in disease phenotype and hip involvement. Affective or anxiety disorders were more frequent in axSpA vs. HC (26.6% vs. 2.3%, p<0.001); depressive symptoms were also more frequent (20.2% vs. 2.27%, p<0.001) and higher in active vs. inactive disease (30.0% vs. 3.45%, p<0.001). Compared with HCs, patients had higher cf-mtDNA and lower DII (both p<0.01), with a trend towards lower T/S ratio. Females had higher T/S ratio and DII than males, and higher cf-mtDNA overall. Lower T/S ratio was associated with affective disorders, while only CRP independently predicted depressive symptom severity. Conclusions: Altered cfDNA profiles, particularly increased cf-mtDNA and reduced DII, are associated with axSpA, disease activity and mental burden, supporting their potential as biomarkers of disease-related processes.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 18 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.15.26368092